Impact of pemafibrate in patients with metabolic dysfunction-associated steatotic liver disease complicated by dyslipidemia: A single-arm prospective study.
Ono H, Atsukawa M, Tsubota A, Arai T, Suzuki K, Higashi T, Kitamura M, Shioda-Koyano K, Kawano T, Yoshida Y, Okubo T, Hayama K, Itokawa N, Kondo C, Nagao M, Iwabu M, Iwakiri K.
Ono H, et al. Among authors: iwabu m.
JGH Open. 2024 Apr 2;8(4):e13057. doi: 10.1002/jgh3.13057. eCollection 2024 Apr.
JGH Open. 2024.
PMID: 38572327
Free PMC article.